Tags: Drug.
Ecromeximab is a chimeric monoclonal antibody being developed for the treatment of malignant melanoma.This drug was developed by Kyowa Hakko Kogyo Co. Ltd.
Loading...
This page contains content from the copyrighted Wikipedia article "Ecromeximab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.